How a biotech revolution catapulted this East Bay company to a $100M IPO

This company has helped fuel the revolution in single-cell sequencing, which has accelerated discoveries in cancer, immunology and neuroscience.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news